Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer

R. Iacovelli, M. Cossu Rocca, L. Galli, U. De Giorgi, R. Sabbatini, M. Santoni, A. Mosca, G. Fornarini, F. Massari, C. Masini, M. Bersanelli, E. Biasco, C. Lolli, A. Guida, R. Berardi, C. Terrone, A. Pastorino, A. Ardizzoni, C. Pinto, S. ButiF. Nolè, G. Tortora

Research output: Contribution to journalArticlepeer-review

Cite this